Chison Medical Revenue vs. Cash Flow From Operations
| 688358 Stock | 27.10 0.59 2.23% |
Total Revenue | First Reported 2019-03-31 | Previous Quarter 140.6 M | Current Value 107 M | Quarterly Volatility 31.9 M |
For Chison Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Chison Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Chison Medical Technologies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Chison Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Chison Medical Technologies over time as well as its relative position and ranking within its peers.
Chison |
Chison Medical Techn Cash Flow From Operations vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Chison Medical's current stock value. Our valuation model uses many indicators to compare Chison Medical value to that of its competitors to determine the firm's financial worth. Chison Medical Technologies is the top company in revenue category among its peers. It also is number one stock in cash flow from operations category among its peers making about 0.18 of Cash Flow From Operations per Revenue. The ratio of Revenue to Cash Flow From Operations for Chison Medical Technologies is roughly 5.63 . At present, Chison Medical's Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Chison Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chison Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Chison Revenue vs. Competition
Chison Medical Technologies is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 23.98 Billion. Chison Medical holds roughly 483.84 Million in revenue claiming about 2.02% of equities under Health Care industry.
Chison Cash Flow From Operations vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Chison Medical |
| = | 483.84 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Chison Medical |
| = | 85.91 M |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Chison Cash Flow From Operations Comparison
Chison Medical is currently under evaluation in cash flow from operations category among its peers.
Chison Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Chison Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Chison Medical will eventually generate negative long term returns. The profitability progress is the general direction of Chison Medical's change in net profit over the period of time. It can combine multiple indicators of Chison Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 18.2 M | 19.2 M | |
| Operating Income | 131 M | 97.4 M | |
| Net Income From Continuing Ops | 146.5 M | 104.4 M | |
| Income Before Tax | 162.2 M | 116.3 M | |
| Net Income | 146.5 M | 104.4 M | |
| Interest Income | 19 M | 19.9 M |
Chison Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Chison Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Chison Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Chison Medical's important profitability drivers and their relationship over time.
Use Chison Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chison Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chison Medical will appreciate offsetting losses from the drop in the long position's value.Chison Medical Pair Trading
Chison Medical Technologies Pair Trading Analysis
The ability to find closely correlated positions to Chison Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chison Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chison Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chison Medical Technologies to buy it.
The correlation of Chison Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chison Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chison Medical Techn moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chison Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Chison Medical position
In addition to having Chison Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Chison Stock
To fully project Chison Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Chison Medical Techn at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Chison Medical's income statement, its balance sheet, and the statement of cash flows.